Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 11/20 | 0.42 |
| ▸ | CNR2 | P34972 | 9/20 | 0.42 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.41 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.40 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | TTK | P33981 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4019604 | 0.85 | SMN1; SMN2 (0.40) | CNR1MALT1 | |
| SCHEMBL4022727 | 0.81 | CHRNA7 (0.42) | KDM4EALDH1A1MAPTMAPK1 | |
| SCHEMBL4019475 | 0.78 | CNR2 (0.46) | CNR1CNR2 | |
| SCHEMBL4026894 | 0.77 | CNR1 (0.49) | CNR1CNR2 | |
| SCHEMBL4184513 | 0.77 | CNR1 (0.49) | CNR1 | |
| SCHEMBL4021673 | 0.77 | CNR1 (0.54) | CNR1CNR2 | |
| SCHEMBL4022474 | 0.76 | CNR1 (0.51) | CNR1CNR2 | |
| SCHEMBL4020217 | 0.76 | CNR1 (0.49) | CNR1CNR2 | |
| SCHEMBL4024815 | 0.75 | RPA1 (0.44) | CNR1CNR2 | |
| SCHEMBL4026409 | 0.75 | CNR1 (0.46) | CNR1CNR2MALT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009095752-A1 | FUSED PYRAZOLE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS | GLENMARK PHARMACEUTICALS, S.A. (US) | 2009-08-06 | — | — | WO | disclosed |